Fourteen cancer drugs are in short supply, causing national concern among patients and providers. Distributors and the U.S. Food and Drug Administration (FDA) have said the issue has to do with the supply chain and residual issues from the closure of a manufacturing plant in India over the winter.
Production at the plant in India...
